3 Defendants Oppose MDL For Onglyza Diabetes Drug Federal Lawsuits
WASHINGTON, D.C. — The three defendants in a proposed Onglyza/Kombiglyze multidistrict litigation on Nov. 2 told a federal judicial panel that it should deny centralization because there are fewer than 40...To view the full article, register now.
Already a subscriber? Click here to view full article